OmniAb (OABI) Other Non Operating Income (2023 - 2026)
OmniAb (OABI) posted quarterly Other Non Operating Income of $77000.0 for Q1 2026, up 7600.0% year-over-year from $1000.0 in Q1 2025, and up 1640.0% quarter-over-quarter from -$5000.0 in Q4 2025.
Powered by 
Analysis
OmniAb (OABI) Other Non Operating Income (2023 - 2026) Analysis & Trends
OmniAb (OABI) has reported Other Non Operating Income for 4 consecutive years, with $77000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income rose 7600.0% year-over-year to $77000.0; the TTM figure through Mar 2026 stood at $91000.0 (up 750.0% YoY), while the FY2025 annual figure was $15000.0, up 200.0% from the prior year.
- Other Non Operating Income climbed to $77000.0 in Q1 2026 per OABI's latest filing, from -$5000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $77000.0 in Q1 2026 and bottomed at -$9000.0 in Q2 2024.
- Historically, Other Non Operating Income has averaged $7090.9 across 4 years, with a median of -$3000.0 in 2023.
- Annual changes were most pronounced in 2025 — Other Non Operating Income slumped 350.0% — and 2026, when it surged 7600.0%.
- OmniAb's Other Non Operating Income stood at -$3000.0 in 2023, then surged by 166.67% to $2000.0 in 2024, then plunged by 350.0% to -$5000.0 in 2025, then jumped by 1640.0% to $77000.0 in 2026.
- Business Quant data shows OABI's Other Non Operating Income at $77000.0 in Q1 2026, -$5000.0 in Q4 2025, and -$8000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.21 Bn | 132.36 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.73 Bn | 58.55 Bn | 1.37 Bn |
| 4 | Moderna | 57.59 Bn | 52.46 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 40.13 Bn | 35.04 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.55 Bn | 32.24 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.60 Bn | 27.77 Bn | - |
| 9 | Insmed | 27.70 Bn | 26.54 Bn | 358.27 Mn |
| 10 | OmniAb | 582.80 Mn | 530.80 Mn | 12.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9,000.00 |
| Mar 31, 2026 | 77,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | 27,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | -4,000.00 |